ProQR Therapeutics N.V (PRQR) Research & Development: 2021-2025
Historic Research & Development for ProQR Therapeutics N.V (PRQR) over the last 5 years, with Sep 2025 value amounting to -$13.0 million.
- ProQR Therapeutics N.V's Research & Development fell 25.29% to -$13.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.5 million, marking a year-over-year increase of 54.83%. This contributed to the annual value of $38.8 million for FY2024, which is 42.81% up from last year.
- Per ProQR Therapeutics N.V's latest filing, its Research & Development stood at -$13.0 million for Q3 2025, which was down 0.31% from -$12.9 million recorded in Q2 2025.
- ProQR Therapeutics N.V's 5-year Research & Development high stood at $92.9 million for Q4 2022, and its period low was -$15.5 million during Q3 2022.
- Moreover, its 3-year median value for Research & Development was -$7.6 million (2024), whereas its average is $2.4 million.
- As far as peak fluctuations go, ProQR Therapeutics N.V's Research & Development skyrocketed by 751.81% in 2022, and later slumped by 74.39% in 2024.
- Quarterly analysis of 5 years shows ProQR Therapeutics N.V's Research & Development stood at -$14.2 million in 2021, then soared by 751.81% to $92.9 million in 2022, then slumped by 50.69% to $45.8 million in 2023, then spiked by 44.91% to $66.4 million in 2024, then declined by 25.29% to -$13.0 million in 2025.
- Its Research & Development was -$13.0 million in Q3 2025, compared to -$12.9 million in Q2 2025 and -$13.0 million in Q1 2025.